Skip to main content

Table 2 Association between KSHV seropositivity or antibody levels and study population. KSHV seropositivity in children

From: Variation in KSHV prevalence between geographically proximate locations in Uganda

Study

Children 1–13 years

Children 5 years only

KSHV seropositivity

*OR (95% CI), P value

KSHV seropositivity

**OR (95% CI), P value

EMaBSa

15% (184/1222)

1

15% (184/1222)

1

GPCb

47% (1597/3425)

3.16 (2.38, 4.19), < 0.0001

35% (111/315)

3.08 (2.31, 4.12), < 0.0001

LaVIISWAc

56% (305/513)

5.79 (3.82, 8.77), < 0.0001

54% (37/61)

7.81 (3.67, 16.62), < 0.0001

  1. *Adjusted for age group, sex and HIV serostus ** Adjusted for sex and HIV serostatus. *OR: odds ratio. Logistic regression analysis was used for statistical analysis allowing for the survey design for the LaVIISWA trial. aEMaBS-Entebbe Mother and Baby Study, bGPC-General Population Cohort, cLaVIISWA-Lake Victoria Island Intervention Study on Worms and Allergy related diseases
Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us